기사 (3건) 리스트형 웹진형 타일형 Daewoong Pharma, Nabota 3Q Cumulative Sales KRW 113.3 billion...Overseas Sales 83% Occupied Daewoong Pharma, Nabota 3Q Cumulative Sales KRW 113.3 billion...Overseas Sales 83% Occupied Daewoong Pharmaceutical "Nabota, High-dose Administration Clinical trial →Long-lasting effect proved" Daewoong Pharmaceutical "Nabota, High-dose Administration Clinical trial →Long-lasting effect proved" [Industry Analysis] Daewoong Pharmaceutical's overseas business is expected to grow rapidly...Expectations for the global launch of two new drugs [Industry Analysis] Daewoong Pharmaceutical's overseas business is expected to grow rapidly...Expectations for the global launch of two new drugs 처음처음1끝끝